10
WORLD GASTROENTEROLOGY NEWS JULY 2019
Editorial | Expert Point of View | WCOG 2019 | WDHD News | WGO & WGOF News | WGO Global Guidelines | Calendar of Events
Romero-Hernández F, Furuzawa-
Carballeda J, Hernández-Molina
G, et al. Autoimmune comorbidity
in achalasia patients. J Gastroenterol
Hepatol. 2018;33:203-208.
Booy JD, Takata J, Tomlinson G,
Urbach DR. The prevalence of autoimmune
disease in patients
with esophageal achalasia.
Dis Esophagus. 2012;25:209-13.
Becker J, Haas SL, Mokrowiecka A,
et al. The HLA-DQβ1 insertion is
a strong achalasia risk factor and
displays a geospatial north-south
gradient among Europeans. Eur J
Hum Genet 2016;24:1228-1231.
Furuzawa-Carballeda J, Zuñiga J,
Hernández-Zaragoza DI,et al.
An original Eurasian haplotype,
HLA-DRB1*14:54-DQB1*05:03,
influences the susceptibility to
idiopathic achalasia. PLoS One.
2018;13:e0201676.
Savarino E, Gemignani L, Zentilin P,
De Bortoli N, Malesci A, Mastracci
L, Fiocca R, Savarino V.
Achalasia with dense eosinophilic
infiltrate responds to steroid therapy.
Clin Gastroenterol Hepatol
2011; 9: 1104-1106.